logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Krishnan Ramaswamy

Pfizer
H指数:18
被引数:1,787

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non–small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors

ALK阳性转移性非小细胞肺癌患者接受一线ALK酪氨酸激酶抑制剂治疗后，脑转移的实世界发病率、患病率及临床影响。

Lung Cancer
IF4.4
2025-11-280
PRE
Geoffrey Liu; Devin Abrahami; Priya Ramachandran; Rossella Messina; Nada Rifi; Hongbo Yang; Xinglei Chai; Benjamin Li; Krishnan Ramaswamy; Puneeth Iyengar; Nathan A. Pennell; Alice T. Shaw
Retrospective Analysis of Racial Differences in Treatment Patterns and Prostate-Specific Antigen Responses Among Patients with Prostate Cancer Treated with Relugolix in the Veterans Health Administration

退伍军人健康管理中接受Relugolix治疗的前列腺癌患者治疗模式及前列腺特异性抗原反应的种族差异回顾性分析

Advances in Therapy
IF4
2025-11-010
OA
Stephen J. Freedland; Krishnan Ramaswamy; Abhishek Kavati; Wei Gao; Juan F. Razo; Michele Cole; Benjamin Li; Hongbo Yang; Tracy Guo; Grace Chen; Rana R. McKay
Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States?

通俗易懂的总结：种族或收入状况是否会影响美国患有转移性去势敏感前列腺癌（mCSPC）的患者的癌症治疗方案？

FUTURE ONCOLOGY
IF2.6
2025-04-250
OA
George, Daniel J.; Agarwal, Neeraj; Ramaswamy, Krishnan; Klaassen, Zachary; Bitting, Rhonda L.; Russell, David; Sandin, Rickard; Emir, Birol; Yang, Hongbo; Song, Wei; Lin, Yilu; Hong, Agnes; Gao, Wei; Freedland, Stephen J.
Plain language summary: how long do patients with metastatic castration-resistant prostate cancer (mCRPC) live when taking abiraterone or enzalutamide in the real world?

非专业语言摘要：在接受阿比特龙或恩扎卢特胺治疗时，转移性去势抵抗性前列腺癌（mCRPC）患者的真实世界生存期是多久？

FUTURE ONCOLOGY
IF2.6
2025-04-250
OA
George, Daniel J.; Ramaswamy, Krishnan; Yang, Hongbo; Liu, Qing; Zhang, Adina; Greatsinger, Alexandra; Ivanova, Jasmina; Thompson, Betty; Emir, Birol; Hong, Agnes; Freedland, Stephen J.
Brain metastases and mortality in patients with ALK plus metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study

ALK阳性转移性非小细胞肺癌患者接受第二代ALK酪氨酸激酶抑制剂作为一线靶向治疗时的脑转移和死亡率：一项观察性队列研究

LUNG CANCER
IF4.4
2025-03-010
PRE
Uprety, Dipesh; Abrahami, Devin; Marcum, Zachary A.; Li, Benjamin; Sang, Angela; Davis, Matthew; Rifi, Nada; Kelton, John M.; Ramaswamy, Krishnan; Sanghvi, Parag; Bazhenova, Lyudmila

研究方向

暂未获取到该数据
S
Stephen J. Freedland
H 指数:98论文数:1,642被引数:4.3万
D
Daniel J. George
H 指数:50论文数:493被引数:1.6万
R
Rickard Sandin
H 指数:19论文数:145被引数:2,353
A
Agnes Hong
H 指数:9论文数:58被引数:264
H 指数:0论文数:81被引数:0
H
Hongbo Yang
H 指数:29论文数:213被引数:2,742
H 指数:0论文数:64被引数:0
B
Birol Emir
H 指数:31论文数:230被引数:4,434
W
Wei Gao
H 指数:17论文数:69被引数:764
J
Jack Mardekian
H 指数:40论文数:365被引数:5,709